Therapeutic myocardial angiogenesis via vascular endothelial growth factor gene therapy: Moving on down the road

Circulation

Volumn 102, Issue 9, 2000, Pages 940-942

  Patterson, Cam ^a   Runge, Marschall S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Angiogenesis; Editorials; Gene therapy; Growth substances; Imaging

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR;

ANGIOGENESIS; COLLATERAL CIRCULATION; EDITORIAL; FEASIBILITY STUDY; GENE EXPRESSION; GENE THERAPY; HEART MUSCLE ISCHEMIA; HUMAN; PLASMID; PRIORITY JOURNAL; SAFETY; TREATMENT INDICATION;

EID: 0034730107     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.9.940     Document Type: Editorial

References (14)

1. Left ventricular electrome-chanical mapping to assess efficacy of phVEGF165 gene transfer for therapeutic angiogenesis in chronic myocardial ischemia
2. Therapeutic angiogenesis
3. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs
4. Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia
5. Direct gene transfer into mouse muscle in vivo
6. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion
7. 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
8. 165 as sole therapy for myocardial ischemia
9. A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart
10. Comparison between left ventricular electromechanical mapping and radionuclide perfusion imaging for detection of myocardial viability
11. Left ventricular electromechanical mapping: Current understanding and diagnostic potential
12. Percutaneous myocardial gene transfer of phVEGF-2
13. Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
14. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis